IQHQ Appoints Janice Sears and Anshul Mangal as Independent Members to its Board of Directors

Rhea-AI Summary

IQHQ has appointed two new independent directors to its Board: Janice Sears and Anshul Mangal, both bringing extensive experience in life sciences and commercial real estate.

Sears, a former leader at Bank of America, has served on various boards including Sonder Holdings (SOND) and Invitation Homes (INVH). Mangal is the founder of Project Farma and has deep ties to the biotech industry. These appointments come as IQHQ expands its development portfolio in key markets such as San Francisco, San Diego, Boston, and the UK.

CEO Steve Rosetta highlights their expertise as pivotal for future growth.

Positive

• Addition of experienced directors Janice Sears and Anshul Mangal
• Sears has a strong track record in financial and commercial real estate sectors
• Mangal brings entrepreneurial and biotech industry expertise
• Appointments align with IQHQ's expansion strategy in key innovation markets

Negative

• None.

New Board members bring extensive life science, financial, investor, and entrepreneurial experience to guide IQHQ’s expanding development portfolio

SAN DIEGO--(BUSINESS WIRE)-- IQHQ, Inc., a premier life sciences real estate development company, today announced key additions to its Board of Directors – naming Janice Sears and Anshul Mangal as independent directors. With decades of relevant life science and commercial real estate experience, Sears and Mangal join IQHQ at a critical juncture as the company builds out its development portfolio in San Francisco, San Diego, Boston, and the United Kingdom.

“We are pleased to add Janice and Anshul to our esteemed Board of Directors,” said Steve Rosetta, CEO of IQHQ. “Janice brings an unparalleled track record of financial, investor, and commercial real estate expertise, which will play a critical role in our future growth plans. Anshul is a biotech entrepreneur, experienced executive, philanthropist, and attorney, who will inform our work to develop innovative districts that meet the needs of leading life science companies while attracting top talent.”

Sears is the Retired President of the San Francisco market of Bank of America. During her accomplished career at Bank of America, she also served as the West Coast Region Head for Real Estate Investment Banking, and the West Coast Region Head for Commercial Real Estate. Prior to joining Bank of America, she held prominent positions at Chemical Bank and Citigroup in New York City. Sears has served on numerous Boards, including current director roles for Sonder Holdings Inc. (NASDAQ: SOND) and Invitation Homes (NYSE: INVH). She holds a Bachelor of Science in Economics and Marketing from the University of Delaware.

“I am pleased and honored to be joining the Board of Directors at IQHQ and to work with a seasoned and talented management team, as well as a group of sophisticated life sciences investors,” said Sears. “The pandemic has shown everyone the importance of this sector and IQHQ is extraordinarily well positioned to help the sector grow and thrive in key innovation markets.”

Mangal brings a wide range of entrepreneurial, management, and philanthropic experience to the Board. He currently serves as the founder and president of Project Farma (PF), a premier worldwide biologics and advanced therapy engineering consulting firm and Precision ADVANCE, Precision Medicine Group’s cell and gene collective. Mangal is also the Chief Strategy Officer for The Institute for Life Changing Medicines, a nonprofit organization that identifies, develops, and promotes access to life-changing medicines for diseases not considered commercially viable. Prior to PF, Mangal was a patent litigator at Jones Day and a pro bono attorney who helped refugees secure asylum in the United States. He earned a Bachelor of Science degree in Computer and Electrical Engineering from Purdue University and his Juris Doctor from the John Marshall Law School (now the University of Illinois Chicago School of Law).

“I am excited to join the IQHQ Board of Directors and use my expertise to further the development of IQHQ’s portfolio,” said Mangal. “I have been fortunate to work closely with life science leaders to improve the lives of patients, and am excited to further that work by helping these leaders have a place for their innovation to flourish via IQHQ.”

About IQHQ

IQHQ is giving progress a home, empowering the life science community to thrive and succeed by creating and developing districts that inspire innovation and drive progress and growth. IQHQ’s focus is to acquire, develop, and operate sustainable transformational life science districts in the innovation hubs of San Francisco, San Diego, and Boston in the United States, and the United Kingdom. IQHQ has offices in San Diego and Boston. To learn more, visit iqhqreit.com or follow us on LinkedIn or Instagram.

View source version on businesswire.com: https://www.businesswire.com/news/home/20230123005179/en/

For IQHQ

Dom Slowey

781-710-0014

dslowey@sloweymcmanus.com

Travis Small

617-538-9041

tsmall@sloweymcmanus.com

Source: IQHQ, Inc.

FAQ

Who are the new independent directors appointed by IQHQ?

IQHQ has appointed Janice Sears and Anshul Mangal as independent directors.

What experience do Janice Sears and Anshul Mangal bring to IQHQ?

Janice Sears has extensive experience in financial and commercial real estate, while Anshul Mangal is a biotech entrepreneur with significant management expertise.

How will the new board members impact IQHQ's growth?

Their expertise is expected to support IQHQ's expansion plans in markets such as San Francisco, San Diego, Boston, and the UK.

What companies are Janice Sears currently associated with?

Janice Sears is a current director for Sonder Holdings (SOND) and Invitation Homes (INVH).

What is the significance of adding new directors to IQHQ's Board?

The addition of new directors is crucial for guiding the company's strategic growth, particularly in the life sciences real estate market.